Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean L Mbisa

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|August 7, 2014
Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length Gag-protease genesKatherine A Sutherland, Jean L Mbisa, Jade Ghosn, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJean L Mbisa, Juan Ledesma, Peter Kirwan, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 18, 2020
Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipientsVanesa Anton-Vazquez, Varun Mehra, Jean L Mbisa, et al.
AIDS Research and Human Retroviruses|May 9, 2015
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase InhibitorsJonathan K Kayondo, Nicaise Ndembi, Chris M Parry, et al.
Plos One|February 14, 2019
Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal KenyaAmin S Hassan, David F Bibby, Shalton M Mwaringa, et al.
The Journal of Antimicrobial Chemotherapy|November 19, 2016
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UKKate El Bouzidi, Ellen White, Jean L Mbisa, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2013
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort studyDavid I Dolling, David T Dunn, Katherine A Sutherland, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
Clinical evaluation of a Hepatitis C Virus whole-genome sequencing pipeline for genotyping and resistance testingDaniel Bradshaw, David F Bibby, Carmen F Manso, et al.
The Journal of Infectious Diseases|May 8, 2024
Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting AntiviralsJean L Mbisa, Zena Lapp, David F Bibby, et al.
Retrovirology|May 17, 2011
The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domainsJean L Mbisa, Ravi K Gupta, Desire Kabamba, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|August 7, 2014
Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length Gag-protease genesKatherine A Sutherland, Jean L Mbisa, Jade Ghosn, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJean L Mbisa, Juan Ledesma, Peter Kirwan, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 18, 2020
Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipientsVanesa Anton-Vazquez, Varun Mehra, Jean L Mbisa, et al.
AIDS Research and Human Retroviruses|May 9, 2015
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase InhibitorsJonathan K Kayondo, Nicaise Ndembi, Chris M Parry, et al.
Plos One|February 14, 2019
Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal KenyaAmin S Hassan, David F Bibby, Shalton M Mwaringa, et al.
The Journal of Antimicrobial Chemotherapy|November 19, 2016
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UKKate El Bouzidi, Ellen White, Jean L Mbisa, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2013
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort studyDavid I Dolling, David T Dunn, Katherine A Sutherland, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
Clinical evaluation of a Hepatitis C Virus whole-genome sequencing pipeline for genotyping and resistance testingDaniel Bradshaw, David F Bibby, Carmen F Manso, et al.
The Journal of Infectious Diseases|May 8, 2024
Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting AntiviralsJean L Mbisa, Zena Lapp, David F Bibby, et al.
Retrovirology|May 17, 2011
The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domainsJean L Mbisa, Ravi K Gupta, Desire Kabamba, et al.
Pageof 5